ASTHMA

A novel tissue inhibitor of metalloproteinase-1 (TIMP-1) polymorphism associated with asthma in Australian women

F Lose^1,2, P J Thompson^1,3, D Duffy⁵, G A Stewart⁴, M-A Kedda^1,2,3

¹ Asthma and Allergy Research Institute and Centre for Asthma, Allergy and Respiratory Research, University of Western Australia, Perth, WA 6009, Australia
² Western Australian Institute for Medical Research and the Centre for Medical Research, University of Western Australia, Perth, WA 6009, Australia
³ The CRC for Asthma, Australia
⁴ Microbiology, School of Biomedical and Chemical Sciences, University of Western Australia, Perth, WA 6009, Australia
⁵ Genetic Epidemiology Laboratory, Queensland Institute of Medical Research, Brisbane, QLD 4006, Australia

Correspondence to:
Correspondence to:
A/Prof P J Thompson
Asthma and Allergy Research Institute, QEII Medical Centre, Nedlands, WA 6009, Australia; aari{at}aari.uwa.edu.au

Background: Airway remodelling is a characteristic feature of chronic asthma and there is evidence that an airway imbalance between levels of matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of metalloproteinases-1 (TIMP-1) is associated with airway remodelling. On this basis, we hypothesised that polymorphisms in the MMP-9 and TIMP-1 genes were associated with the disease process.

Methods: A number of MMP-9 and TIMP-1 gene polymorphisms were examined in an adult white Australian population of mild (n = 259), moderate (n = 213) and severe (n = 71) asthmatics and non-asthmatic controls (n = 406) using PCR-RFLP and PCR-SSCP analyses.

Results: MMP-9 –1562C>T and 836G>A (Arg279Gln) were not associated with asthma (p0.15) or asthma severity (p0.13), and TIMP-1 434T>C (Phe124Phe) was not associated with asthma in women (p = 0.094) or men (p = 0.207). In this population, MMP-9 –861C>T and TIMP-1 323C>T (Pro87Pro) were not informative (with minor allele frequencies of <1%), and MMP-9 –1702T>A and TIMP-1 595C>T (Ser178Phe) were not detectable. However, a novel polymorphism was detected in the TIMP-1 gene 536C>T (Ile158Ile) which was significantly associated with asthma in women (p = 0.011; OR = 5.54, 95% CI 1.66 to 34.4) but not in men (p = 1.0). 536C>T was found to be in linkage disequilibrium with 434T>C, and haplotype analysis supported an association with asthma (p = 0.014).

Conclusions: This is the first reported association between a polymorphism in the TIMP-1 gene and asthma, and supports the hypothesis that the protease/antiprotease balance has an important role in this common disease.

Abbreviations: ECM, extracellular matrix; EPA, erythroid potentiating activity; ESE, exonic splice enhancer; HCI, human collagenase inhibitor; FEV₁, forced expiratory volume in 1 second; MMP-9, matrix metalloproteinase-9; OR, odds ratio; PCR-RFLP, polymerase chain reaction-restriction fragment length polymorphism; PCR-SSCP, polymerase chain reaction-single strand conformation polymorphism; SFRS2, splicing factor, arginine/serine-rich 2; SFRS6, splicing factor, arginine/serine-rich 6; SNP, single nucleotide polymorphism; TIMP-1, tissue inhibitor of metalloproteinases-1

Keywords: matrix metalloproteinase-9 (MMP-9); tissue inhibitor of metalloproteinases-1 (TIMP-1); asthma; polymorphism

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• BURKHARDT, J., PETIT-TEIXEIRA, E., TEIXEIRA, V. H., KIRSTEN, H., GARNIER, S., RUEHLE, S., OESER, C., WOLFRAM, G., SCHOLZ, M., MIGLIORINI, P., BALSA, A., WESTHOVENS, R., BARRERA, P., ALVES, H., PASCUAL-SALCEDO, D., BOMBARDIERI, S., DEQUEKER, J., RADSTAKE, T. R., Van RIEL, P., van de PUTTE, L., BARDIN, T., PRUM, B., BUCHEGGER-PODBIELSKI, U., EMMRICH, F., MELCHERS, I., CORNELIS, F., AHNERT, P. (2009). Association of the X-Chromosomal Genes TIMP1 and IL9R with Rheumatoid Arthritis. The Journal of Rheumatology 36: 2149-2157 [Abstract] [Full Text]  
• Vermeer, P. D., Denker, J., Estin, M., Moninger, T. O., Keshavjee, S., Karp, P., Kline, J. N., Zabner, J. (2009). MMP9 modulates tight junction integrity and cell viability in human airway epithelia. Am. J. Physiol. Lung Cell. Mol. Physiol. 296: L751-L762 [Abstract] [Full Text]  
• Sampsonas, F., Kaparianos, A., Lykouras, D., Karkoulias, K., Spiropoulos, K. (2007). DNA sequence variations of metalloproteinases: their role in asthma and COPD. Postgrad. Med. J. 83: 244-250 [Abstract] [Full Text]  
• Greenlee, K. J., Werb, Z., Kheradmand, F. (2007). Matrix Metalloproteinases in Lung: Multiple, Multifarious, and Multifaceted. Physiol. Rev. 87: 69-98 [Abstract] [Full Text]  
• Verstappen, J., Von den Hoff, J.W. (2006). Tissue Inhibitors of Metalloproteinases (TIMPs): Their Biological Functions and Involvement in Oral Disease. JDR 85: 1074-1084 [Abstract] [Full Text]  
• Vendelin, J., Bruce, S., Holopainen, P., Pulkkinen, V., Rytila, P., Pirskanen, A., Rehn, M., Laitinen, T., Laitinen, L. A., Haahtela, T., Saarialho-Kere, U., Laitinen, A., Kere, J. (2006). Downstream target genes of the neuropeptide S-NPSR1 pathway. Hum Mol Genet 15: 2923-2935 [Abstract] [Full Text]  
• STICKEL, F., OSTERREICHER, C. H. (2006). THE ROLE OF GENETIC POLYMORPHISMS IN ALCOHOLIC LIVER DISEASE. Alcohol Alcohol 41: 209-224 [Abstract] [Full Text]  
• Johnson, S R (2005). TIMP-1 in asthma: guilty by association. Thorax 60: 617-618 [Full Text]